# Viking Therapeutics, Inc.: Form 8-K, filed May 23, 2024

- Company: [Viking Therapeutics, Inc.](/companies/vktx.md) (CIK 1607678)
- Form: 8-K
- Filed: 2024-05-23
- Accepted by EDGAR: May 22, 2024, 19:54 ET
- Period: 2024-05-21
- Accession: 0000950170-24-063707
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1607678/000095017024063707/vktx-20240521.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1607678/000095017024063707/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1607678/000095017024063707/vktx-20240521.htm

Filed May 23, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-063707. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.